| |
| |
|
| Insider
Information: |
Levy Guy |
| Relationship: |
Director |
| City: |
Greenwich |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
14,871 |
|
|
Indirect Shares
|
2,655,553 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,670,424 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lyra Therapeutics, Inc. |
LYRA |
10% Owner |
2020-05-05 |
0 |
2020-05-05 |
155,000 |
Premium* |
|
|
Bioatla, Inc. |
BCAB |
Director |
2021-09-30 |
14,871 |
2021-09-30 |
2,500,553 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2021-09-30 |
4 |
A |
$28.00 |
$7,501,200 |
I/I |
267,900 |
1,115,817 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2021-08-24 |
4 |
S |
$39.65 |
$21,677,012 |
I/I |
(546,709) |
847,917 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2021-06-17 |
4 |
S |
$39.16 |
$15,664,000 |
I/I |
(400,000) |
270,553 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2020-12-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,790,472 |
1,790,472 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2020-12-18 |
4 |
B |
$18.00 |
$25,000,020 |
I/I |
1,388,890 |
333,333 |
2.1 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
10% Owner |
– – • |
2020-05-05 |
4 |
A |
$0.00 |
$0 |
I/I |
442,938 |
442,948 |
0 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
10% Owner |
– – • |
2020-05-05 |
4 |
OE |
$8.63 |
$270,827 |
I/I |
31,382 |
474,330 |
0 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
10% Owner |
– – • |
2020-05-05 |
4 |
S |
$16.00 |
$270,544 |
I/I |
(16,909) |
457,421 |
0 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
10% Owner |
– – • |
2020-05-05 |
4 |
B |
$16.00 |
$2,480,000 |
I/I |
155,000 |
155,000 |
1.5 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
